Skip to main content
. 2020 Jun 12;10:9595. doi: 10.1038/s41598-020-66608-3

Figure 3.

Figure 3

Progression Free Survival in a subgroup of patients who completed a total radiation dose of 56–60 Gy, according to the interval between surgery and combined therapy (TMZ + RT). Longrank test for difference for progression-free survival: p-value = 0.1853.